Oral 11ß-HSD1 inhibitor AZD4017 improves wound healing and skin integrity in adults with type 2 diabetes mellitus: a pilot randomized controlled trial. (2022)

First Author: Ajjan RA
Attributed to:  MICA: Treatment According to Response in Giant cEll arTeritis (TARGET) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1530/eje-21-1197

PubMed Identifier: 35113805

Publication URI: http://europepmc.org/abstract/MED/35113805

Type: Journal Article/Review

Volume: 186

Parent Publication: European journal of endocrinology

Issue: 4

ISSN: 0804-4643